(Q35766467)

10 August 2017

title

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma (English)

1 reference

10 August 2017

0 references

4

Jan Lötvall

0 references

Ashley Woodcock

object named as

Ashley Woodcock

series ordinal

1

0 references

William W Busse

series ordinal

3

object named as

William W Busse

1 reference

10 August 2017

2

Eugene R Bleecker

1 reference

10 August 2017

9

Eric D Bateman

1 reference

10 August 2017

7

Loretta Jacques

1 reference

10 August 2017

5

Neil G Snowise

1 reference

10 August 2017

8

Brett Haumann

1 reference

10 August 2017

Lucy Frith

6

1 reference

10 August 2017

publication date

21 December 2011

1 reference

10 August 2017

1 reference

10 August 2017

volume

12

1 reference

10 August 2017

page(s)

160

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-12-160

10 August 2017

exact match

0 references

cites work

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

The Living & Breathing Study: a study of patients' views of asthma and its treatment.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3282675

Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma

2 October 2017

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Fluticasone given once versus twice a day: meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Treatment patterns in the months prior to and after asthma-related emergency department visit

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-12-160

Low-dose inhaled corticosteroids and the prevention of death from asthma

21 January 2018

1 reference

12 December 2020

Assessment of asthma control in primary care

1 reference

12 December 2020

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment

1 reference

12 December 2020

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy

1 reference

12 December 2020

Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma

1 reference

12 December 2020

Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-12-160

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference